SelectQuote Inc (6SJA)

Exactly this is now full steam ahead...doesn't matter what the rest say. We are on fast track forward and even EFS approval could be much quicker than the 30 day window.

Let's go ISOPET now and RDGL soon...imo

Technicals are improving with only the 20 50 and 100 day Moving Average Crossovers remaining in negative position.
Let's Go Knicks.

Copilot on whats the Delay (hopefully this has some truth to it)? i dont think i ever saw this before which sort of helps why so F'ing long for approval!
If MHRA approves DCVax L, it will be the first-ever MHRA approved cancer therapy whose pivotal evidence package relies primarily on an Ext

Global Photonics Economic Forum (GPEF) 2026, taking place 24–25 September 2026 in Málaga, Spain.

Confirmed keynote speakers

Andy Bechtolsheim, Co-Founder & Chief Architect, Arista Networks and founder of Sun Microsystems
Satish Dhanasekaran, President & CEO, Keys

Sales Increased 26.6% and Gross Profit Increased 42.4%
in the Second Quarter of Fiscal 2026 Compared to Same Period in Prior Year

ROANOKE, Va., June 8, 2026 /PRNewswire/ -- Optical Cable Corporation (Nasdaq GM: OCC) ("OCC®" or the "Company") today announced financial results fo

Recognition and enforcement efforts are ongoing. Following service of the complaint in Korea, the Company now awaits Kukbo's response in the Korean proceeding and the further scheduling of the matter by the Korean court. No assurances can be provided regarding the timing of any recovery or the amoun

Symbol
FNMA
Pre-Market
$6.80
+$0.10 (+1.49%)

Looking for a morning dip…

But we win either way I believe.

okpj

Sales Increased 26.6% and Gross Profit Increased 42.4%
in the Second Quarter of Fiscal 2026 Compared to Same Period in Prior Year

ROANOKE, Va., June 8, 2026 /PRNewswire/ -- Optical Cable Corporation (Nasdaq GM: OCC) ("OCC®" or the "Company") today announced financial results fo

So we have waited for years on the NFPA 286 test and we get a head fake instead. Why did they not do the more stringent NFPA 286 test. The ASTM R84 DOESN'T even determine the products FIRE RESISTANCE. I guess they had to give Smarty something PUMP. LOLOL

https://investorshub.advfn.co

Corrected.

100% recommendation for true Eltp king.

You are 1000% correct!!

The market won't be able to ignore those sales agreements the news will trigger. The next few weeks will be critical. Fingers crossed!

He’s too smart to want to be president

Just in retrospect to any legal issue with Tony, the OTC is a breeding ground for deception.  The SEC basically slaps these so called CEO’s on the wrist. In comparison, and this person makes Tony look like a cubscout, check out Bruce Perlowin CEO of HEMP INC. If ya think Tony is going to prison for

$NCRA News June 08, 2026
Nocera Inc. (Nasdaq:NCRA) Advances AI and Acquisition Strategy Through Binding Venture Platform Agreement with U.S.-Based Digital Innovations Grouphttps://finance.yahoo.com/sectors/technology/articles/nocera-inc-nasdaq-ncra-advances-114500788.html

Nexera Technologies Ltd. operates as an e-commerce consumer products goods company. It operates as a holding company of three other e-commerce companies that operate online stores for the sale of various consumer products on the Amazon online marketplace, utilizing the Fulfillment by Amazon, or FBA

We know most of this. However, great interpretations by AI if Enanta wins the suits Vs. Phizer in the U.S. and Europe. I see a large settlement in the works .

The May 11, 2026, hearing in the U.S. Court of Appeals for the Federal Circuit featured oral arguments rather than a final ru

Better day today if you have SIDU $4.43 Pre hours

$HWAL is stacking heavyweights.

Jamie Shortill brings experience in:
✅ Investment banking
✅ Venture capital
✅ Sports & entertainment deals
✅ Media rights & licensing
✅ M&A and capital raises

Former roles tied to WME, PwC, and global fi

$HWAL is stacking heavyweights.

Jamie Shortill brings experience in:
✅ Investment banking
✅ Venture capital
✅ Sports & entertainment deals
✅ Media rights & licensing
✅ M&A and capital raises

Former roles tied to WME, PwC, and global fi

CTNT~~$1.76

That is true. There is a biomarker. But this vaccine samples all of the biomarkers. That is the difference. It could be that vaccine meeting was how to handle data when treating a patient other than GBM. I could see that as conditional approval and there has to be a better reason than GBM to look to

🌐UNCHANGED OUTSTANDING SHARES 6/8/26
Held at DTC 7,993,313,019 6/8/2026

Outstanding Shares 10,511,001,446 04/08/2026 (498M increase)
Restricted 2,517,513,262 04/08/2026
Unrestricted 7,993,488,184 04/08/2026(498M increase)
Held at DTC 7,993,313,019 0